# MHC: Needle, Interosseous

- Device class: 2; regulation: 21 CFR 880.5570; FDA's rule: 510(k) required
- FDA decisions: 2
- 510(k) review time 2021–2025: median 78 days (middle half 53–102)
- Recalls: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 2021: 1
- 2022: 1

## Most-cited predicates
- K203193: BD Intraosseous Infusion System (2021), cited by 1

Source page: https://510kreport.com/product-code/MHC
Data by year (CSV): https://510kreport.com/product-code/MHC.csv